跳至主要内容
临床试验/JPRN-UMIN000012582
JPRN-UMIN000012582已完成未知

Aiphagan addition to prostaglandin analogue(PG) and/or beta-blocker and/or carbonic anhydrase inhibitor in normal pressure glaucoma study - AABC study

AABC study group0 个研究点目标入组 90 人开始时间: 2013年12月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Complications with chronic or recurrent uveitis,scleritis,or corneal herpes. 2.History of ocular trauma or intraocular conventional surgery or laser ocular surgery in the study eye within 3 months before baseline examinations. 3.Any abnormality preventing reliable applanation tonometer in the study eye. 4.Known medical history of allergic to PGAs or beta-blockers. 5.Contraindication of betablockers. 6.Patients using an IOP-lowering drug other than those to be used in the study. 7.Patients using systemic administration of an oral CAI (Diamox,etc.). 8.Patient having serious eyes complications. 9.Women who are pregnant or lactating. 10.Severe dementia 11.Patients who are judged to be inappropriate for participation in the study for other reason by the doctor in charge.

研究者

发起方
AABC study group

相似试验